274.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RMD Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$275.61
Aprire:
$275.08
Volume 24 ore:
624.57K
Relative Volume:
0.64
Capitalizzazione di mercato:
$40.15B
Reddito:
$5.15B
Utile/perdita netta:
$1.40B
Rapporto P/E:
28.83
EPS:
9.51
Flusso di cassa netto:
$1.65B
1 W Prestazione:
+0.91%
1M Prestazione:
-6.65%
6M Prestazione:
+23.00%
1 anno Prestazione:
+10.94%
Resmed Inc Stock (RMD) Company Profile
Nome
Resmed Inc
Settore
Industria
Telefono
(858) 746-2400
Indirizzo
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Confronta RMD con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
RMD
Resmed Inc
|
274.19 | 40.35B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
ISRG
Intuitive Surgical Inc
|
443.99 | 160.51B | 9.15B | 2.63B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
186.05 | 53.46B | 21.39B | 1.61B | 2.55B | 5.56 |
![]()
ALC
Alcon Inc
|
75.00 | 37.18B | 10.03B | 1.07B | 1.39B | 2.17 |
![]()
WST
West Pharmaceutical Services Inc
|
259.94 | 18.03B | 2.96B | 487.70M | 344.00M | 6.68 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-09-18 | Iniziato | Citigroup | Buy |
2025-09-02 | Aggiornamento | CLSA | Hold → Outperform |
2025-07-15 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2025-03-19 | Iniziato | Morgan Stanley | Overweight |
2025-01-16 | Iniziato | Goldman | Buy |
2025-01-10 | Iniziato | Piper Sandler | Neutral |
2024-12-13 | Iniziato | Stifel | Hold |
2024-09-24 | Iniziato | Robert W. Baird | Outperform |
2024-09-18 | Downgrade | Wolfe Research | Peer Perform → Underperform |
2024-09-04 | Downgrade | Needham | Buy → Hold |
2024-06-25 | Downgrade | Oppenheimer | Outperform → Perform |
2024-06-24 | Downgrade | Citigroup | Buy → Neutral |
2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
2023-10-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2023-10-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2023-10-09 | Aggiornamento | JP Morgan | Neutral → Overweight |
2023-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
2023-09-06 | Aggiornamento | Needham | Hold → Buy |
2023-09-05 | Downgrade | UBS | Buy → Neutral |
2023-08-01 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2023-05-23 | Iniziato | UBS | Buy |
2023-04-14 | Iniziato | Mizuho | Buy |
2023-01-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
2022-10-28 | Downgrade | Citigroup | Buy → Neutral |
2022-10-20 | Aggiornamento | BofA Securities | Neutral → Buy |
2022-10-12 | Iniziato | Jefferies | Hold |
2022-09-08 | Aggiornamento | Citigroup | Neutral → Buy |
2022-08-15 | Downgrade | CLSA | Buy → Outperform |
2022-08-12 | Downgrade | Citigroup | Buy → Neutral |
2022-08-12 | Downgrade | JP Morgan | Overweight → Neutral |
2022-08-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2022-06-06 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2022-04-06 | Iniziato | Wolfe Research | Outperform |
2022-01-31 | Aggiornamento | Citigroup | Neutral → Buy |
2022-01-31 | Aggiornamento | Goldman | Neutral → Buy |
2022-01-28 | Aggiornamento | RBC Capital Mkts | Underperform → Sector Perform |
2022-01-24 | Aggiornamento | BofA Securities | Underperform → Neutral |
2022-01-24 | Aggiornamento | JP Morgan | Neutral → Overweight |
2022-01-13 | Aggiornamento | CLSA | Outperform → Buy |
2022-01-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2021-12-21 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2021-12-06 | Aggiornamento | Macquarie | Neutral → Outperform |
2021-10-22 | Aggiornamento | CLSA | Underperform → Outperform |
2021-08-02 | Downgrade | CLSA | Outperform → Sell |
2021-08-02 | Downgrade | Needham | Buy → Hold |
2021-07-28 | Aggiornamento | Jefferies | Underperform → Hold |
2021-07-26 | Downgrade | JP Morgan | Overweight → Neutral |
2021-07-14 | Iniziato | RBC Capital Mkts | Underperform |
2021-06-28 | Downgrade | Citigroup | Buy → Neutral |
2021-06-22 | Aggiornamento | Macquarie | Neutral → Outperform |
2021-06-22 | Iniziato | Robert W. Baird | Neutral |
2021-06-21 | Reiterato | Needham | Buy |
2021-06-16 | Downgrade | BofA Securities | Neutral → Underperform |
2021-06-09 | Aggiornamento | CLSA | Sell → Outperform |
2021-05-21 | Aggiornamento | JP Morgan | Neutral → Overweight |
2021-05-11 | Aggiornamento | Citigroup | Neutral → Buy |
2021-04-30 | Downgrade | Citigroup | Buy → Neutral |
2021-03-16 | Aggiornamento | Needham | Hold → Buy |
2020-11-02 | Aggiornamento | UBS | Neutral → Buy |
2020-10-30 | Aggiornamento | JP Morgan | Underweight → Neutral |
2020-10-27 | Aggiornamento | BofA Securities | Underperform → Neutral |
2020-08-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2020-06-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2020-05-01 | Downgrade | JP Morgan | Neutral → Underweight |
2020-05-01 | Aggiornamento | Oppenheimer | Perform → Outperform |
2020-02-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2020-02-03 | Iniziato | CLSA | Underperform |
2020-01-31 | Downgrade | UBS | Buy → Neutral |
2020-01-10 | Iniziato | Oppenheimer | Perform |
2019-11-22 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2019-07-29 | Aggiornamento | UBS | Neutral → Buy |
2019-07-16 | Downgrade | UBS | Buy → Neutral |
2019-05-06 | Aggiornamento | UBS | Neutral → Buy |
2019-04-18 | Aggiornamento | JP Morgan | Underweight → Neutral |
2019-01-25 | Downgrade | Goldman | Buy → Neutral |
2019-01-25 | Downgrade | JP Morgan | Neutral → Underweight |
2018-10-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
2018-07-02 | Iniziato | Goldman | Buy |
Mostra tutto
Resmed Inc Borsa (RMD) Ultime notizie
ResMed's (NYSE:RMD) investors will be pleased with their respectable 66% return over the last five years - Yahoo Finance
BDF Gestion Sells 1,159 Shares of ResMed Inc. $RMD - MarketBeat
Yarbrough Capital LLC Grows Stake in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Purchased by IFM Investors Pty Ltd - MarketBeat
Assenagon Asset Management S.A. Purchases 28,801 Shares of ResMed Inc. $RMD - MarketBeat
ResMed targets 59-60% gross margins and expanded global reach for AirSense 11 - MSN
Transcript : ResMed Inc. Presents at Bank of America Global Healthcare Conference 2025, Sep-23-2025 12 - MarketScreener
ResMed (NYSE:RMD) Coverage Initiated by Analysts at Citigroup - MarketBeat
Swedbank AB Increases Stake in ResMed Inc. $RMD - MarketBeat
Mn Services Vermogensbeheer B.V. Acquires 1,700 Shares of ResMed Inc. $RMD - MarketBeat
Marshall Financial Group LLC Trims Position in ResMed Inc. $RMD - MarketBeat
Brendan Caldwell's Past Picks: ResMed, Carrier Global Corp & Equifax - BNN Bloomberg
Caitlin John LLC Has $1.45 Million Holdings in ResMed Inc. $RMD - MarketBeat
Pallas Capital Advisors LLC Sells 1,924 Shares of ResMed Inc. $RMD - MarketBeat
Primer: ResMed Inc (RMD AU)Sep 2025 - Smartkarma
Financiere des Professionnels Fonds d investissement inc. Invests $419,000 in ResMed Inc. $RMD - MarketBeat
Czech National Bank Raises Position in ResMed Inc. $RMD - MarketBeat
Resmed Inc Azioni (RMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):